# Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

> **NCT00678054** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 30 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** GM-CSF

## Key facts

- **NCT ID:** NCT00678054
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2000-08-11
- **Final completion:** 2015-10-23
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00678054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00678054, "Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00678054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*